Morrisville-based Cempra Pharmaceuticals (www.cempra.com), a biotechnology company, has closed on $10 million in venture funding from Intersouth Partners, Aisling Capital, Optimer Pharmaceuticals Inc. and banker I. Wistar Morris III. The company has proprietary chemistry technology related to macrolides, which are antibiotics which combat a wide range of bacterial infections. The two-year-old company has now raised $24 million in financing from investors.
Intersouth Partners is a CED member.